1.16 (-%)
As of Oct 31, 2024
Source:
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on utilizing the Processa Regulatory Science Approach, including the principles associated with FDA’s Project Optimus Oncology initiative and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy oncology drug products.
Country | United States |
Headquarters | hanover, maryland |
Phone Number | 443-776-3133 |
Industry | manufacturing |
CEO | David Young |
Website | www.processapharmaceuticals.com |